Top 3 German Growth Stocks With High Insider Ownership In September 2024

As global economic concerns weigh on markets, the German DAX has not been immune, reflecting a 3.20% decline amid renewed fears about growth prospects. Despite these challenges, growth companies with high insider ownership can present compelling opportunities for investors seeking resilience and potential upside. In the current market environment, stocks with strong insider ownership often signal confidence from those who know the company best. This article highlights three German growth stocks that stand out in September 2024 due to their robust insider holdings and promising outlooks.

Top 10 Growth Companies With High Insider Ownership In Germany

Name	Insider Ownership	Earnings Growth
pferdewetten.de (XTRA:EMH)	26.8%	70.6%
Stemmer Imaging (XTRA:S9I)	25.1%	23.2%
Deutsche Beteiligungs (XTRA:DBAN)	39.5%	54.1%
Exasol (XTRA:EXL)	25.3%	117.1%
adidas (XTRA:ADS)	16.6%	41.8%
Alelion Energy Systems (DB:2FZ)	37.4%	106.6%
Beyond Frames Entertainment (DB:8WP)	10.8%	112.2%
R. STAHL (XTRA:RSL2)	37.9%	59.3%
elumeo (XTRA:ELB)	25.8%	120.2%
Your Family Entertainment (DB:RTV)	17.5%	116.8%

Click here to see the full list of 22 stocks from our Fast Growing German Companies With High Insider Ownership screener.

Below we spotlight a couple of our favorites from our exclusive screener.

Hypoport (XTRA:HYQ)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Hypoport SE develops and markets technology platforms for the financial services, property, and insurance industries in Germany, with a market cap of €1.78 billion.

Operations: The company's revenue segments are: Credit Platform €157.97 million, Insurance Platform €66.89 million, and Segment Adjustment €175.87 million.

Insider Ownership: 35%

Revenue Growth Forecast: 12.5% p.a.

Hypoport SE, a growth company with high insider ownership in Germany, reported strong earnings for Q2 2024, with sales of €110.62 million and net income of €2.4 million, reversing last year's losses. The company's revenue is forecast to grow at 12.5% annually, outpacing the German market's 5.5%, while earnings are expected to rise significantly at 35% per year over the next three years despite a highly volatile share price recently.

• Take a closer look at Hypoport's potential here in our earnings growth report.
• The valuation report we've compiled suggests that Hypoport's current price could be inflated.

Verve Group (XTRA:M8G)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Verve Group SE operates a software platform for the automated buying and selling of digital advertising space in North America and Europe, with a market cap of €614.98 million.

Operations: Verve Group SE generates revenue primarily from its Supply Side Platforms (SSP) at €341.35 million and Demand Side Platforms (DSP) at €57.59 million.

Insider Ownership: 25.1%

Revenue Growth Forecast: 12.5% p.a.

Verve Group SE, with substantial insider ownership, reported robust Q2 2024 earnings, showing sales of €102.82 million and net income of €6.26 million, up from €1.74 million a year ago. The company raised its 2024 revenue guidance to €400-€420 million and completed a fixed-income offering of €66.63 million to refinance debt at lower costs. Despite recent share price volatility, Verve's earnings are forecast to grow significantly at 20.5% annually over the next three years.

• Navigate through the intricacies of Verve Group with our comprehensive analyst estimates report here.
• Insights from our recent valuation report point to the potential undervaluation of Verve Group shares in the market.

Redcare Pharmacy (XTRA:RDC)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Redcare Pharmacy NV operates an online pharmacy business across the Netherlands, Germany, Italy, Belgium, Switzerland, Austria, and France with a market cap of €2.42 billion.

Operations: The company's revenue segments include €1.74 billion from the DACH region and €391 million from international markets.

Insider Ownership: 17.7%

Revenue Growth Forecast: 17.1% p.a.

Redcare Pharmacy, with significant insider ownership, reported substantial sales growth for H1 2024 at €1.12 billion compared to €791.94 million a year ago, while reducing its net loss from €14.78 million to €12.07 million. Revenue is forecast to grow at 17.1% annually, outpacing the German market's 5.5%. Despite recent share price volatility and past shareholder dilution, the stock trades at a considerable discount to its estimated fair value and is expected to become profitable within three years.

• Click to explore a detailed breakdown of our findings in Redcare Pharmacy's earnings growth report.
• In light of our recent valuation report, it seems possible that Redcare Pharmacy is trading beyond its estimated value.

Where To Now?

• Unlock more gems! Our Fast Growing German Companies With High Insider Ownership screener has unearthed 19 more companies for you to explore.Click here to unveil our expertly curated list of 22 Fast Growing German Companies With High Insider Ownership.
• Got skin in the game with these stocks? Elevate how you manage them by using Simply Wall St's portfolio, where intuitive tools await to help optimize your investment outcomes.
• Invest smarter with the free Simply Wall St app providing detailed insights into every stock market around the globe.

Looking For Alternative Opportunities?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com